Giving that engineered FGF21 analog has been successfully applied for diabetes treatment in clinical (Gaich et al., 2013), our results may extend the indication of the engineered FGF21 analog from metabolic disorders to hypoxia-related brain diseases such as brain ischemia and acute mountain sickness. The gene discussed is FGF21; the disease is metabolic disease.